U.S. Waives Tariffs on Specialty Drugs from 20 Countries

The U.S. has waived tariffs on specialty drugs from 20 countries, including India, to support rare disease treatments and infertility therapies. This zero percent tariff rate applies to various innovative therapies such as cell and gene therapies, antibody-drug conjugates, and animal pharmaceuticals. The move aims to enhance access to critical medications and promote healthcare advancements.